73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Researcher leads first in-human multiple myeloma study with over 90% response rate

Researcher leads first in-human multiple myeloma study with over 90% response rate

by Indiana University School of MedicineMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Indiana University Melvin and Bren

Researcher leads first in-human multiple myeloma study with over 90% response rate

by Indiana University School of MedicineMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Indiana University Melvin and Bren
Combination therapy outperforms chemotherapy in clinical trial for patients with chronic lymphocytic leukemia

Combination therapy outperforms chemotherapy in clinical trial for patients with chronic lymphocytic leukemia

by University of AmsterdamCredit: Unsplash/CC0 Public DomainChemotherapy has been the most effective treatment to date for young and fit patients with chronic lymphocytic leukemia (CLL). The dise

Combination therapy outperforms chemotherapy in clinical trial for patients with chronic lymphocytic leukemia

by University of AmsterdamCredit: Unsplash/CC0 Public DomainChemotherapy has been the most effective treatment to date for young and fit patients with chronic lymphocytic leukemia (CLL). The dise
Survivorship standards help address the distinct needs of adult cancer survivors

Survivorship standards help address the distinct needs of adult cancer survivors

byAmerican College of SurgeonsCredit: Thirdman from PexelsWith the number of adult cancer survivors in the United States expected to reach 23 million by 2032, the long-term needs of this populat

Survivorship standards help address the distinct needs of adult cancer survivors

byAmerican College of SurgeonsCredit: Thirdman from PexelsWith the number of adult cancer survivors in the United States expected to reach 23 million by 2032, the long-term needs of this populat
Lethal cancer cells buddy up to survive

Lethal cancer cells buddy up to survive

by University of California, IrvineConsistent Metabolic Features in a Second PDA Clonal Cell Model and Media Metabolite Profiling.A. Dose response curves of oligomycin treated KPC clones 28

Lethal cancer cells buddy up to survive

by University of California, IrvineConsistent Metabolic Features in a Second PDA Clonal Cell Model and Media Metabolite Profiling.A. Dose response curves of oligomycin treated KPC clones 28
Staying safe in the sun — a dermatologist helps separate facts from hype

Staying safe in the sun — a dermatologist helps separate facts from hype

by University of California, San FranciscoCredit: Elena ZhukovaSkin cancer is the number-one cancer diagnosis in the United States – it's more common than breast, prostate, and lung cancers c

Staying safe in the sun — a dermatologist helps separate facts from hype

by University of California, San FranciscoCredit: Elena ZhukovaSkin cancer is the number-one cancer diagnosis in the United States – it's more common than breast, prostate, and lung cancers c
Genes responsible for sex-related differences in cancer aggressiveness found in vinegar flies

Genes responsible for sex-related differences in cancer aggressiveness found in vinegar flies

by Institute for Research in Biomedicine (IRB Barcelona)Differences between tumours in male and female vinegar flies. Credit: Cayetano González, IRB BarcelonaAn understanding of the molecular bas

Genes responsible for sex-related differences in cancer aggressiveness found in vinegar flies

by Institute for Research in Biomedicine (IRB Barcelona)Differences between tumours in male and female vinegar flies. Credit: Cayetano González, IRB BarcelonaAn understanding of the molecular bas
Soluble immune checkpoint factors in blood as potential biomarkers of therapeutic efficacy for ICI cancer immunotherapy

Soluble immune checkpoint factors in blood as potential biomarkers of therapeutic efficacy for ICI cancer immunotherapy

by Kindai UniversityThe concentration of soluble PD-L1m PD-1, CTLA4 in plasma were highly correlated with the expression of genes associated with exhaustion in the peripheral CD8+T cells. R valu

Soluble immune checkpoint factors in blood as potential biomarkers of therapeutic efficacy for ICI cancer immunotherapy

by Kindai UniversityThe concentration of soluble PD-L1m PD-1, CTLA4 in plasma were highly correlated with the expression of genes associated with exhaustion in the peripheral CD8+T cells. R valu
Study links mutations in notch gene to role in B cell cancers

Study links mutations in notch gene to role in B cell cancers

by Perelman School of Medicine at the University of PennsylvaniaPeripheral blood with chronic lymphocytic leukemia cells. Credit: Jon Aster, Harvard Medical SchoolNotch is one of the most frequen

Study links mutations in notch gene to role in B cell cancers

by Perelman School of Medicine at the University of PennsylvaniaPeripheral blood with chronic lymphocytic leukemia cells. Credit: Jon Aster, Harvard Medical SchoolNotch is one of the most frequen
Study: Two drugs prevent heart problems in breast cancer patients

Study: Two drugs prevent heart problems in breast cancer patients

by University of KentuckyDr. Maya Guglin chaired a study demonstrating the effectiveness of beta blockers and ACE inhibitors to prevent cardio toxicity in certain breast cancer patients. Credit:

Study: Two drugs prevent heart problems in breast cancer patients

by University of KentuckyDr. Maya Guglin chaired a study demonstrating the effectiveness of beta blockers and ACE inhibitors to prevent cardio toxicity in certain breast cancer patients. Credit:
A new therapeutic target for metastatic and resistant prostate cancers

A new therapeutic target for metastatic and resistant prostate cancers

by IDIBELL-Bellvitge Biomedical Research InstituteÁlvaro Aytés & Katia Ruggero. Credit: IDIBELLProstate Cancer researchers from the Bellvitge Biomedical Research Institute (IDIBELL), led by D

A new therapeutic target for metastatic and resistant prostate cancers

by IDIBELL-Bellvitge Biomedical Research InstituteÁlvaro Aytés & Katia Ruggero. Credit: IDIBELLProstate Cancer researchers from the Bellvitge Biomedical Research Institute (IDIBELL), led by D
New test shows promise for detecting hard-to-find cervical cancers

New test shows promise for detecting hard-to-find cervical cancers

byAlbert Einstein College of MedicineCredit: Unsplash/CC0 Public DomainIn findings with potentially important implications for cervical cancer screening, scientists at the Montefiore Einstein Ca

New test shows promise for detecting hard-to-find cervical cancers

byAlbert Einstein College of MedicineCredit: Unsplash/CC0 Public DomainIn findings with potentially important implications for cervical cancer screening, scientists at the Montefiore Einstein Ca
Mouse studies have revealed more about the mechanisms behind cancer drugs in trials

Mouse studies have revealed more about the mechanisms behind cancer drugs in trials

by Agency for Science, Technology and Research (A*STAR), SingaporeDNA damage (red) in the spleen of a mouse that expresses the mutant form of CDK1 that cannot be suppressed by phosphorylation. Cr

Mouse studies have revealed more about the mechanisms behind cancer drugs in trials

by Agency for Science, Technology and Research (A*STAR), SingaporeDNA damage (red) in the spleen of a mouse that expresses the mutant form of CDK1 that cannot be suppressed by phosphorylation. Cr